Browse Category

Medical Technology News 29 July 2025

AI Just Diagnosed You—Now What? The Rise of Superhuman Doctors Made of Code

AI Just Diagnosed You—Now What? The Rise of Superhuman Doctors Made of Code

A boy in the United States with three years of chronic pain was diagnosed by an AI chatbot with spina bifida occulta, later confirmed by a specialist. Microsoft’s AI Diagnostic Orchestrator (MAI-DxO) achieved an 85% correct diagnosis rate on nearly 300 challenging NEJM case studies, compared with 20% for 21 experienced physicians, while ordering 20% fewer tests. Google’s conversational diagnostic AI prototype outperformed physicians on hypothetical primary care cases, scoring about 59% accuracy versus 33% for human doctors. PathAI announced a major 2024 partnership with Quest Diagnostics, with Quest acquiring PathAI’s laboratory and integrating AI across its pathology labs. IDx-DR
29 July 2025
1 4 5 6

Stock Market Today

IREN stock whipsaws after earnings as bitcoin rebounds; Microsoft GPU financing in focus

IREN stock whipsaws after earnings as bitcoin rebounds; Microsoft GPU financing in focus

7 February 2026
IREN Limited shares rose 5.1% to $41.83 in after-hours trading Friday as bitcoin jumped 11.4% to $71,198, lifting crypto-linked stocks. The company reported $184.7 million in quarterly revenue, with $167.4 million from bitcoin mining and $17.3 million from AI cloud services. Net loss reached $155.4 million. IREN recently announced $3.6 billion in GPU financing for a Microsoft contract and a new Oklahoma data center.
Netflix stock price rises after-hours as DOJ widens scrutiny of Warner deal

Netflix stock price rises after-hours as DOJ widens scrutiny of Warner deal

7 February 2026
The U.S. Justice Department is investigating Netflix’s business practices as part of its review of the proposed Warner Bros Discovery deal, the Wall Street Journal reported Friday. Netflix shares rose 1.6% to $82.20 in after-hours trading. Warner expects a shareholder vote on the deal in March. Paramount Skydance’s rival bid remains active.
JPMorgan stock price jumps after hours as Dow tops 50,000; HSBC lifts rating

JPMorgan stock price jumps after hours as Dow tops 50,000; HSBC lifts rating

7 February 2026
JPMorgan Chase shares rose 3.9% to $322.40 in after-hours trading Friday as the Dow closed above 50,000 for the first time. HSBC upgraded JPMorgan and raised its price target, while the bank disclosed a $3 billion subordinated note sale. Other major banks also gained. Investors are watching for signals on rates and loan growth ahead of JPMorgan’s Feb. 10 conference appearance.
Go toTop